| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
Trifluoromethanesulfonate lithium does not have a defined pharmacological target. It is a chemical reagent used primarily in electrochemistry and organic synthesis. The compound is being investigated for use in electrochemical devices such as fuel cells and supercapacitors. Its mechanism of action is physical rather than biological, involving the conduction of lithium ions in electrolyte applications.
|
|---|---|
| ln Vitro |
In vitro, trifluoromethanesulfonate lithium is primarily used as a chemical reagent. It is utilized in polymer electrolytes for energy storage applications. The compound is a biochemical reagent that could be utilized as a biomaterial or organic/chemical reagent in biomedical research. As a lithium salt, it can be used in studies involving lithium ion transport and electrochemical processes.
|
| ln Vivo |
In vivo data for trifluoromethanesulfonate lithium are not available, as the compound is not intended for in vivo administration. It is a chemical reagent used primarily in electrochemistry and materials science. The compound is not designed for therapeutic use and has no established in vivo pharmacokinetic or pharmacodynamic profile.
|
| Enzyme Assay |
For in vitro electrochemical experiments, trifluoromethanesulfonate lithium is used as an electrolyte salt. Standard protocols involve dissolving the compound in appropriate solvents (e.g., organic carbonates, ethers) at concentrations typically ranging from 0.1-1.0 M. The electrolyte solution is used in electrochemical cells for battery testing, conductivity measurements, and cyclic voltammetry. The compound's purity and water content are critical parameters for electrochemical performance.
|
| Cell Assay |
For in vitro cell-based experiments, trifluoromethanesulfonate lithium is not typically used directly in cell culture. It is a chemical reagent used primarily in electrochemistry and materials science. The compound may be used in the synthesis of materials that are subsequently tested in biological applications, but it is not added directly to cell cultures as a test compound.
|
| Animal Protocol |
In vivo animal studies for trifluoromethanesulfonate lithium are not applicable, as the compound is a chemical reagent used in electrochemistry and materials science. No animal studies have been conducted for this compound as a therapeutic agent, and it is not intended for diagnostic or therapeutic use in animals or humans.
|
| ADME/Pharmacokinetics |
Pharmacokinetic data for trifluoromethanesulfonate lithium are not available, as the compound is not a drug and is not administered to living organisms. The compound has a molecular weight of 156.01 g/mol. As a salt, it would dissociate into lithium and triflate ions in aqueous solution. Lithium ions have well-characterized pharmacokinetics, but the triflate anion is not a drug substance.
|
| Toxicity/Toxicokinetics |
Trifluoromethanesulfonate lithium is a research chemical and should be handled with appropriate laboratory safety precautions. As a salt, it may cause skin and eye irritation. The compound has a melting point >300°C. Specific LD₅₀ values, acute toxicity classifications, and chronic toxicity data are not available in the public literature. Standard safety practices include the use of personal protective equipment and working in a fume hood.
|
| Additional Infomation |
Trifluoromethanesulfonate lithium (Lithium triflate, CAS 33454-82-9) is a research-grade chemical reagent, not an FDA-approved pharmaceutical drug. Its primary applications are as an electrolyte salt in lithium-ion batteries and other electrochemical devices. The compound is also investigated for use in fuel cells and supercapacitors. It could be utilized as a biomaterial or organic/chemical reagent in biomedical research. No clinical trials or approved therapeutic indications exist for this compound.
|
| Molecular Formula |
CF3LIO3S
|
|---|---|
| Molecular Weight |
156.01
|
| Exact Mass |
155.968
|
| CAS # |
33454-82-9
|
| Related CAS # |
1493-13-6 (Parent)
|
| PubChem CID |
3664839
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1,9 g/cm3
|
| Boiling Point |
162ºC at 760mmHg
|
| Melting Point |
>300 °C(lit.)
|
| LogP |
1.132
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
9
|
| Complexity |
163
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=S(C(F)(F)F)([O-])=O.[Li+]
|
| InChi Key |
MCVFFRWZNYZUIJ-UHFFFAOYSA-M
|
| InChi Code |
InChI=1S/CHF3O3S.Li/c2-1(3,4)8(5,6)7;/h(H,5,6,7);/q;+1/p-1
|
| Chemical Name |
lithium;trifluoromethanesulfonate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4098 mL | 32.0492 mL | 64.0985 mL | |
| 5 mM | 1.2820 mL | 6.4098 mL | 12.8197 mL | |
| 10 mM | 0.6410 mL | 3.2049 mL | 6.4098 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
